Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Almac to Expand Development Capacity | Contract Pharma
Breaking News

Almac to Expand Development Capacity

Investing £16 million in formulation and analytical development services at Charnwood Campus

Almac Group is investing £16 million to expand its formulation and analytical development services at Charnwood Campus in Loughborough, a science, technology and enterprise park, with an operational start date targeted for 1Q17. Almac will occupy the formulation development and analytical testing facilities at the site, which will complement development & GMP services offered from its Craigavon NI Headquarters. 
 
The Charnwood facilities were originally designed and built by a global Pharma company as part of its in-house formulation development, clinical manufacturing and analytical testing capabilities. Almac is recommissioning the facilities with operations focusing initially on expanding both non-potent and potent solid oral dose processing, creating approximately 180 new jobs in the next five years.  
 
Graeme McBurney, managing director, Almac Pharma Services said, “As we experience increased client demand for our pharmaceutical development and niche commercial manufacturing services, this latest expansion will significantly enhance Almac’s offering, increasing capacity and capability and further demonstrating our continued commitment to support our global clients in the development and manufacturing of their drug products.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters